UiPath (NYSE:PATH) Reaches New 52-Week Low After Analyst Downgrade

UiPath Inc. (NYSE:PATHGet Free Report) hit a new 52-week low during mid-day trading on Thursday after Barclays lowered their price target on the stock from $25.00 to $16.00. Barclays currently has an equal weight rating on the stock. UiPath traded as low as $11.81 and last traded at $11.96, with a volume of 19708038 shares traded. The stock had previously closed at $18.30.

A number of other analysts have also commented on PATH. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $29.00 price objective on shares of UiPath in a research note on Monday, April 1st. Evercore ISI reduced their price target on shares of UiPath from $27.00 to $13.00 and set an “in-line” rating for the company in a research report on Thursday. Canaccord Genuity Group raised their price objective on shares of UiPath from $27.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. Mizuho cut their target price on shares of UiPath from $25.00 to $14.00 and set a “neutral” rating on the stock in a research note on Thursday. Finally, William Blair lowered UiPath from an “outperform” rating to a “market perform” rating in a report on Thursday. Fifteen investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $20.24.

View Our Latest Analysis on PATH

Insider Activity at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $21.66, for a total value of $866,400.00. Following the completion of the sale, the chief financial officer now directly owns 660,762 shares in the company, valued at $14,312,104.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last quarter, insiders sold 96,000 shares of company stock valued at $2,023,440. 22.37% of the stock is owned by corporate insiders.

Institutional Trading of UiPath

A number of institutional investors and hedge funds have recently made changes to their positions in PATH. Intech Investment Management LLC increased its holdings in shares of UiPath by 3.1% during the 4th quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock valued at $356,000 after acquiring an additional 426 shares during the last quarter. 180 Wealth Advisors LLC lifted its holdings in UiPath by 0.3% in the 4th quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock worth $4,497,000 after purchasing an additional 492 shares during the last quarter. Global Financial Private Client LLC boosted its position in UiPath by 9.3% during the first quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock worth $144,000 after purchasing an additional 551 shares during the period. Bleakley Financial Group LLC grew its holdings in UiPath by 4.9% during the fourth quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after purchasing an additional 598 shares during the last quarter. Finally, Simplicity Solutions LLC raised its position in shares of UiPath by 4.9% in the fourth quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after purchasing an additional 598 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Price Performance

The stock’s 50 day moving average price is $20.13 and its two-hundred day moving average price is $22.06. The firm has a market capitalization of $6.87 billion, a price-to-earnings ratio of -71.00 and a beta of 1.01.

UiPath (NYSE:PATHGet Free Report) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The firm had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. As a group, equities research analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.